Association of lipid lowering drugs and the risk of systemic lupus erythematosus: a drug target Mendelian randomization

Background and objective: An interaction between low-density lipoprotein level, lipid-lowering drugs, and systemic lupus erythematosus (SLE) was reported by previous studies. However, whether lipid-lowering drugs provided protective effect for reducing the risk of SLE was unclear. We aimed to clarif...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Tong, Ye, Ling, Wang, Shenglan, Huang, Jie, Zhang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642506/
https://www.ncbi.nlm.nih.gov/pubmed/37964871
http://dx.doi.org/10.3389/fphar.2023.1258018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642506/
https://www.ncbi.nlm.nih.gov/pubmed/37964871
http://dx.doi.org/10.3389/fphar.2023.1258018

Ejemplares similares